SCHEMBL17829276

SCHEMBL17829276

c1ccc(-c2nc(-c3ccccc3)nc(-c3ccc(-c4cccc5cccc(-c6ccc(-c7cccnc7)cc6)c45)cc3)n2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 3/20 0.49
CYP19A1 P11511 2/20 0.49
CYP11B2 P19099 2/20 0.49
CYP17A1 P05093 1/20 0.49
ALDH1A1 P00352 6/20 0.48
MAPT P10636 5/20 0.48
TSHR P16473 2/20 0.48
POLB P06746 1/20 0.48
MKNK1 Q9BUB5 3/20 0.47
MKNK2 Q9HBH9 3/20 0.47
TNF P01375 1/20 0.47
SMN1; SMN2 Q16637 3/20 0.47
KDM4E B2RXH2 3/20 0.47
HPGD P15428 3/20 0.47
TP53 P04637 2/20 0.47
NPC1 O15118 2/20 0.47
RAB9A P51151 2/20 0.47
HSD17B10 Q99714 2/20 0.47
CYP2A6 P11509 3/20 0.46
CYP1A2 P05177 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17598639 0.97 CYP11B1 (0.46) CYP11B1CYP19A1CYP11B2CYP17A1ALDH1A1
SCHEMBL17829293 0.88 TNF (0.54) CYP11B1CYP19A1CYP11B2CYP17A1ALDH1A1
SCHEMBL17655896 0.87 ALDH1A1 (0.48) ALDH1A1MAPTTSHRPOLBTNF
SCHEMBL17829272 0.86 SMN1; SMN2 (0.50) ALDH1A1MAPTTSHRTNFSMN1; SMN2
SCHEMBL4620048 0.85 TNF (0.54) CYP11B1CYP19A1CYP11B2CYP17A1ALDH1A1
SCHEMBL16716602 0.85 CYP19A1 (0.50) CYP11B1CYP19A1CYP11B2CYP17A1ALDH1A1
SCHEMBL16716533 0.85 ALDH1A1 (0.50) ALDH1A1MAPTTSHRPOLBTNF
SCHEMBL17944660 0.85 CYP2A6 (0.62) CYP11B1CYP19A1CYP11B2CYP17A1ALDH1A1
SCHEMBL2254917 0.85 CYP2A6 (0.62) CYP11B1CYP19A1CYP11B2CYP17A1ALDH1A1
SCHEMBL19039937 0.85 CYP2A6 (0.62) CYP11B1CYP19A1CYP11B2CYP17A1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160172598-A1 HETERO RING COMPOUND AND ORGANIC LIGHT EMITTING DIODE COMPRISING SAME LG CHEM, LTD. (KR) 2016-06-16 US disclosed
US-20160172598-A1 HETERO RING COMPOUND AND ORGANIC LIGHT EMITTING DIODE COMPRISING SAME LG CHEM, LTD. (KR) 2016-06-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160172598-A1 HETERO RING COMPOUND AND ORGANIC LIGHT EMITTING DIODE COMPRISING SAME CRY1, CRY2, PER2 CYP11B1 939/4885CYP19A1 375/4885CYP11B2 661/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.